hznp-ex231_2018.htm

EX-23.1 7 hznp-ex231_2018.htm EX-23.1 hznp-ex231_2018.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (No. 333-198852) and Form S-8 (No. 333-198865, 333-203933, 333-211118) of Horizon Pharma plc of our report dated February 27, 2017 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP
Chicago, Illinois
February 27, 2017